Effects of ketanserin on the discrimination of electrical stimulation of the dorsal raphe nucleus in rats

Neuropharmacology

Volumn 36, Issue 4-5, 1997, Pages 631-636

  Mokler, D J ^a   Abbruzzese, S ^a   Trumble, V ^a   Whitten, B ^a  

^a UNIVERSITY OF NEW ENGLAND   (United States)

Author keywords

5 HT; 5 HT2 receptor; Behavior; Hallucinogens; Ketanserin

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; KETANSERIN; LITHIUM CHLORIDE; PSYCHEDELIC AGENT; SACCHARIN; SEROTONIN 2 AGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN 2 RECEPTOR; SEROTONIN 2A AGONIST; SEROTONIN 2C AGONIST;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DORSAL RAPHE NUCLEUS; ELECTROSTIMULATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PAIRED ASSOCIATE LEARNING; PRIORITY JOURNAL; RAT; STIMULUS RESPONSE; TASTE AVERSION;

AMPHETAMINES; ANIMALS; CUES; DISCRIMINATION (PSYCHOLOGY); ELECTRIC STIMULATION; GENERALIZATION, STIMULUS; KETANSERIN; MALE; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; SACCHARIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SWEETENING AGENTS; TASTE;

EID: 0030904126     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00053-1     Document Type: Article

References (38)

1. Aghajanian G. K., Rosecrans J. A. and Sheard M. H. (1967) Serotonin: Release in the forebrain by stimulation of midbrain raphé. Science 156: 402-403.
2. Aghajanian G. K., Haigler H. J. and Bloom F. E. (1972) Lysergic acid diethylamide and serotonin: Direct actions on serotonin-containing neurons in rat brain. Life Science 11: 615-622.
3. Appel J. B., White F. J. and Holohean A. M. (1982) Analyzing mechanism(s) of hallucinogenic drug action with drug discrimination procedures. Neuroscience of Biobehavioural Reviews 6: 529-536.
4. Arnt J. (1989) Characterization of the discriminative stimulus properties induced by 5-HT1 and 5-HT2 agonists in rats. Pharmacology and Toxicology 64: 165-172.
5. Aulakh C. S., Mazzola-Pomietto P., Hulihan-Giblin B. A. and Murphy D. L. (1995) Lack of cross-tolerance for hypophagia induced by DOI versus m-CPP suggests separate mediation by 5-HT2A and 5-HT2C receptors, respectively. Neuropsychopharmacology 13: 1-8.
6. Aulakh C. S., Mazzola-Pomietto P., Wozniak K. M., Hill J. L. and Murphy D. L. (1994) Evidence that 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane-induced hypophagia and hyperthermia in rats is mediated by serotonin-2A receptors. Journal of Pharmacology and Experimental Therapeutics 270: 127-132.
7. 2 receptors and serotonergic axons in rat neocortex. Brain Research 453: 315-328.
8. 1C receptor agonist. Journal of Pharmacology and Experimental Therapeutics 258: 891-896.
9. Callahan P. M. and Appel J. B. (1988) Differences in the stimulus properties of 3,4-methylene-dioxyamphetamine and 3,4-methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline. Journal of Pharmacology and Experimental Therapeutics 246: 866-870.
10. Cunningham K. A., Callahan P. M. and Appel J. B. (1985) Differentiation between the stimulus effects of 1-5-hydroxytryptophan and LSD. European Journal of Pharmacology 108: 179-186.
11. Duda N. J. and Moore K. E. (1985) Simultaneous measurement of 5-hydroxytryptophan and 3,4-dihydroxyphenylalanine in rat brain by HPLC with electrochemical detection following electrical stimulation of the dorsal raphé nucleus. Journal of Neurochemistry 44: 128-133.
12. Glennon R. A. (1986) Discriminative stimulus properties of the serotonergic agent 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI). Life Science 39: 825-830.
13. 2 agonists or antagonists. Neuropsychopharmacology. 3: 509-517.
14. Glennon R. A., Young R., Rosecrans J. A. and Kallman M. J. (1980) Hallucinogenic agents as discriminative stimuli: A correlation with serotonin receptor affinities. Psychopharmacology 68: 155-158.
15. Glennon R. A. and Rosecrans J. A. (1982) Indolealkylamine and phenalkylamine hallucinogens: A brief overview. Neuroscience and Biobehavioural Reviews 6: 489-497.
16. Glennon R. A., Young R. and Rosecrans J. A. (1983) Antagonism of the effect of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists. European Journal of Pharmacology 91: 189-196.
17. Hirschhorn I. D., Hayes R. L. and Rosecrans J. A. (1975) Discriminative control of behavior by electrical stimulation of the dorsal raphé nucleus: Generalization to lysergic acid diethylamide (LSD). Brain Research 86: 134-138.
18. Houdouin F., Cespuglio R. and Jouvet M. (1991) Effects induced by the electrical stimulation of the nucleus raphé dorsalis upon hypothalamic release of 5-hydroxyindole compounds and sleep parameters in the rat. Brain Research 565: 48-56.
19. Kidd E. J., Garratt J. C. and Marsden C. A. (1991) Effects of repeated treatment with 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on the autoregulatory control of dorsal raphé 5-HT neuronal firing and cortical 5-HT release. European Journal of Pharmacology 200: 131-139.
20. Lin G. C. and Glennon R. A. (1994) Hallucinogens: An Update. U. S. Department of Health and Human Services, Washington, D.C.
21. Lyon R. A., Titeler M., Seggel M. R. and Glennon R. A. (1988) Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens. European Journal of Pharmacology 145: 291-297.
22. McKenna D. J., Repke D. B., Lo L. and Peroutka S. J. (1990) Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes. Neuropharmacology 29: 193-198.
23. Mokier D. J., Stoudt K. W. and Rech R. H. (1985) The 5HT2 antagonist pirenperone reverses disruption of FR-40 by hallucinogenic drugs. Pharmacology and Biochemistry of Behaviour 22: 677-682.
24. Mokler D. J., Whitten B., Gully A., Field S. and Dixon M. (1993) Discrimination of electrical stimulation (ES) of the dorsal raphe nucleus (DRN), generalization to the 5-HT2 agonist DOI and correlation with changes in 5-HT levels in forebrain by microdialysis. Society for Neuroscience Abstracts 19: 1181.
25. Mokler D. J., Dixon M. and Stambaugh L. (1994a) Electrical stimulation of the dorsal raphé nucleus as a discriminative stimulus: Generalization to (±)-DOI. Pharmacology, Biochemistry and Behavior 48: 1041-1045.
26. 2 agonist DOI or electrical stimulation (ES) of the dorsal raphé nucleus (DRN). Society forl Neuroscience Abstracts 20: 287.
27. Paxinos G. and Watson C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
28. Pierce P. A. and Peroutka S. J. (1989) Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex. Psychopharmacology 97: 118-122.
29. Rech R. H. and Gudelsky G. A. (1988) 5-HT Agonists as Psychoactive Drugs. NPP Books, Ann Arbor, Mich.
30. Rosecrans J. A., Krynock G. M., Newlon P. G., Chance W. T. and Kallman M. J. (1978) Central mechanisms of drugs as discriminative stimuli: Involvement of serotonin pathways. In Stimulus Properties of Drugs: Ten Years of Progress, eds Colpaert F. C. and Rosecrans J. A., pp. 83-98. Elsevier/North Holland Biomed Press, Amsterdam.
31. Shannon N. J., Gunnet J. W. and Moore K. E. (1986) A comparison of biochemical indices of 5-hydroxytryptamine neuronal activity following electrical stimulation of the dorsal raphé nucleus. Journal of Neurochemistry 47: 958-965.
32. Sharp T., Bramwell S. R. and Grahame-Smith D. G. (1990) Release of endogenous 5-hydroxytryptamine in rat ventral hippocampus evoked by electrical stimulation of the dorsal raphé nucleus as detected by microdialysis: Sensitivity to tetrodotoxin, calcium and calcium antagonists. Neuroscience 39: 629-637.
33. Sheard M. H. and Aghajanian G. K. (1968) Stimulation of the midbrain raphé: Effect on serotonin metabolism. Journal of Pharmacology and Experimental Therapeutics 163: 425-430.
34. Silverman P. B. and Ho B. T. (1978) Stimulus properties of dom: commonality with other hallucinogens. Stimulus Properties of Drugs: Ten Years of Progress, pp. 189-198.
35. Sloviter R. S., Drust E. G., Damiano B. P. and Connor J. D. (1980) A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic mediation of behavioral effects in rats. Journal of Pharmacology and Experimental Therapeutics 214: 231-238.
36. Wing L. L., Tapson G. S. and Geyer M. A. (1990) 5HT-2 mediation of acute behavioral effects of hallucinogens in rats. Psychopharmacology 100: 417-425.
37. Winter J. C. (1974) Hallucinogens as discriminative stimuli. Federal Proceedings 33: 1825-1832.
38. 2 agonist, DOI, on 5-HT neuronal firing in the dorsal raphé nucleus and 5-HT release and metabolism in the frontal cortex. British Journal of Pharmacology 99: 221-222.